According to Harvard Bioscience's latest financial reports the company has a price-to-book ratio of 0.275048.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2024-12-31 | 1.32 | -57.7% |
2023-12-31 | 3.13 | 95.61% |
2022-12-31 | 1.60 | -54.06% |
2021-12-31 | 3.48 | 57.75% |
2020-12-31 | 2.20 | 54.63% |
2019-12-31 | 1.43 | -0.78% |
2018-12-31 | 1.44 | 0.99% |
2017-12-31 | 1.42 | -2.02% |
2016-12-31 | 1.45 | -4.43% |
2015-12-31 | 1.52 | -21.43% |
2014-12-31 | 1.93 | 22.88% |
2013-12-31 | 1.57 | 27.46% |
2012-12-31 | 1.23 | 6.91% |
2011-12-31 | 1.15 | -9.77% |
2010-12-31 | 1.28 | -8.8% |
2009-12-31 | 1.40 | 14.95% |
2008-12-31 | 1.22 | -35.94% |
2007-12-31 | 1.91 | -13.12% |
2006-12-31 | 2.19 | 10.73% |
2005-12-31 | 1.98 | 46.94% |
2004-12-31 | 1.35 | -50.28% |
2003-12-31 | 2.71 | 142.02% |
2002-12-31 | 1.12 |